Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000018

Options or other derivatives

  • EVP, Chief Scientific Officer acquired 27,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BENNETT C FRANK · EVP, Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-01-02 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +27,200 $52.87 2034-01-01 27,200 27,200 D
Loading xslF345X05/edgardoc.xml…